Literature DB >> 1934605

Complement deficiencies and meningococcal disease.

P Densen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1934605      PMCID： PMC1554037          DOI： 10.1111/j.1365-2249.1991.tb06209.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  12 in total

1.  [ESSENTIAL HYPOCOMPLEMENTEMIA].

Authors:  A HAESSIG; J F BOREL; P AMMANN; M THOENI; R BUETLER
Journal:  Pathol Microbiol (Basel)       Date:  1964

2.  Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination.

Authors:  P Densen; J M Weiler; J M Griffiss; L G Hoffmann
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

3.  Complement activation and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; T E Mollnes; P Kierulf
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

4.  Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis.

Authors:  M Nagata; T Hara; T Aoki; Y Mizuno; H Akeda; S Inaba; K Tsumoto; K Ueda
Journal:  J Pediatr       Date:  1989-02       Impact factor: 4.406

Review 5.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

6.  The role of C9 in complement-mediated killing of Neisseria.

Authors:  G R Harriman; A F Esser; E R Podack; A C Wunderlich; A I Braude; T F Lint; J G Curd
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease.

Authors:  P Brandtzaeg; P Kierulf; P Gaustad; A Skulberg; J N Bruun; S Halvorsen; E Sørensen
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

8.  Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.

Authors:  C Söderström; J H Braconier; H Käyhty; A G Sjöholm; B Thuresson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

9.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  19 in total

1.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

2.  Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.

Authors:  M Schlesinger; H Kayhty; R Levy; C Bibi; N Meydan; J Levy
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

3.  Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.

Authors:  D J Sikkema; K E Friedman; B Corsaro; A Kimura; S W Hildreth; D V Madore; S A Quataert
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).

Authors:  Maguy Daures; Michele John; Cécile Veysseyre Balter; Olivier Simon; Yann Barguil; Isabelle Missotte; Jean-Paul Grangeon; Sylvie Laumond-Barny; Martine Noel; Laurent Besson-Leaud; Pierre-Emmanuel Spasic; Aurélie de Suremain; Ann-Claire Gourinat; Elodie Descloux
Journal:  J Clin Immunol       Date:  2014-10-29       Impact factor: 8.317

5.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 6.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

7.  Two mutations of the C7 gene, c.1424G > A and c.281-1G > T, in two Korean families.

Authors:  Hee Jung Kang; Chang-Seok Ki; Yeon-Sook Kim; Mina Hur; So Ick Jang; Ki Sik Min
Journal:  J Clin Immunol       Date:  2006-03-22       Impact factor: 8.317

8.  Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency.

Authors:  Chester A Alper; Jianhua Xu; Katherine Cosmopoulos; Brian Dolinski; Rosanne Stein; Gabriel Uko; Charles E Larsen; Devendra P Dubey; Peter Densen; Lennart Truedsson; Gunnar Sturfelt; Anders G Sjöholm
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

9.  Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.

Authors:  K Høgåsen; T E Mollnes; P Brandtzaeg
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Meningococcal disease associated with an acute post-streptococcal complement deficiency.

Authors:  Nikolaos Daskas; Katie Farmer; Richard Coward; Michel Erlewyn-Lajeunesse
Journal:  Pediatr Nephrol       Date:  2007-02-10       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.